EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuropharmacological Effects of the Dichloromethane Extract from the Stems of Argemone ochroleuca Sweet (Papaveraceae) and Its Active Compound Dihydrosanguinarine

Eunice Yáñez-Barrientos iD, Juan Carlos Barragan-Galvez iD, Sergio Hidalgo-Figueroa iD, Alfonso Reyes-Luna iD, Maria L Gonzalez-Rivera iD, David Cruz Cruz iD, Mario Alberto Isiordia-Espinoza iD, Martha Alicia Deveze-Álvarez, Clarisa Villegas Gómez iD, Angel Josabad Alonso-Castro iD

Pharmaceuticals · 18.08.2023 · 16 (8) · 1175

DOI: 10.3390/ph16081175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 18.08.2023. Verfasst von Eunice Yáñez-Barrientos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Noria Alta, Colonia Noria Alta Guanajuato, Guanajuato 3…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Guanajuato, University of Guanajuato.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Argemone ochroleuca Sweet (Papaveraceae) is used in folk medicine as a sedative and hypnotic agent. This study aimed to evaluate the anxiolytic-like, sedative, antidepressant-like, and anticonvulsant activities of a dichloromethane extract of A. ochroleuca stems (AOE), chemically standardized using gas chromatography–mass spectrometry (GC–MS), and its active compound dihydrosanguinarine (DHS). The anxiolytic-like, sedative, antidepressant-like, and anticonvulsant activities of the AOE (0.1–50 mg/kg p.o.) and DHS (0.1–10 mg/kg p.o.) were evaluated using murine models. A possible mechanism for the neurological actions induced by the AOE or DHS was assessed using inhibitors of neurotransmission pathways and molecular docking. Effective dose 50 (ED50) values were calculated by a linear regression analysis. The AOE showed anxiolytic-like activity in the cylinder exploratory test (ED50 = 33 mg/kg), and antidepressant-like effects in the forced swimming test (ED50 = 3 mg/kg) and the tail suspension test (ED50 = 23 mg/kg), whereas DHS showed anxiolytic-like activity (ED50 = 2 mg/kg) in the hole board test. The AOE (1–50 mg/kg) showed no locomotive affectations or sedation in mice. A docking study revealed the affinity of DHS for α2-adrenoreceptors and GABAA receptors. The anxiolytic-like and anticonvulsant effects of the AOE are due to GABAergic participation, whereas the antidepressant-like effects of the AOE are due to the noradrenergic system. The noradrenergic and GABAergic systems are involved in the anxiolytic-like actions of DHS.

Schlagwörter

Stichwörter der Autor:innen

Argemone ochroleuca Sweetanticonvulsantantidepressantanxiolytic

Autor:innen und Institutionen

  • Departamento de Química, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Noria Alta, Colonia Noria Alta Guanajuato, Guanajuato 36050, Mexico.
  • Departamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Noria Alta, Colonia Noria Alta Guanajuato, Guanajuato 36050, Mexico.
  • CONAHCyT-División de Biología Molecular, Instituto Potosino de Investigación Científica y Tecnológica A.C., San Luis Potosí 78216, Mexico.
  • Instituto de Investigación en Ciencias Médicas, Departamento de Clínicas, División de Ciencias Biomédicas, Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos 47620, Jalisco, Mexico.

ORCID-Profile: Eunice Yáñez-Barrientos, Juan Carlos Barragan-Galvez, Sergio Hidalgo-Figueroa, Alfonso Reyes-Luna, Maria L Gonzalez-Rivera, David Cruz Cruz, Mario Alberto Isiordia-Espinoza, Clarisa Villegas Gómez, Angel Josabad Alonso-Castro

Förderung

  • Universidad de Guanajuato
  • University of Guanajuato

Zitieren

APA

Yáñez-Barrientos, E., Barragan-Galvez, J. C., Hidalgo-Figueroa, S., Reyes-Luna, A., Gonzalez-Rivera, M. L., Cruz Cruz, D., Isiordia-Espinoza, M. A., Deveze-Álvarez, M. A., Villegas Gómez, C., & Alonso-Castro, A. J. (2023). Neuropharmacological Effects of the Dichloromethane Extract from the Stems of Argemone ochroleuca Sweet (Papaveraceae) and Its Active Compound Dihydrosanguinarine. Pharmaceuticals, 16(8), 1175. https://doi.org/10.3390/ph16081175

Vancouver

Yáñez-Barrientos E, Barragan-Galvez JC, Hidalgo-Figueroa S, Reyes-Luna A, Gonzalez-Rivera ML, Cruz Cruz D, et al. Neuropharmacological Effects of the Dichloromethane Extract from the Stems of Argemone ochroleuca Sweet (Papaveraceae) and Its Active Compound Dihydrosanguinarine. Pharmaceuticals. 2023;16(8):1175. doi:10.3390/ph16081175

BibTeX
@article{YezBarrientos2023,
  author = {Yáñez-Barrientos, Eunice and Barragan-Galvez, Juan Carlos and Hidalgo-Figueroa, Sergio and Reyes-Luna, Alfonso and Gonzalez-Rivera, Maria L and Cruz Cruz, David and Isiordia-Espinoza, Mario Alberto and Deveze-Álvarez, Martha Alicia and Villegas Gómez, Clarisa and Alonso-Castro, Angel Josabad},
  title = {Neuropharmacological Effects of the Dichloromethane Extract from the Stems of Argemone ochroleuca Sweet (Papaveraceae) and Its Active Compound Dihydrosanguinarine},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {8},
  pages = {1175},
  doi = {10.3390/ph16081175}
}
Kostenlos starten →